Blaine Davis | executive |
Carsten Brunn | executive |
Joseph Schwartz | analyst |
Kristen Kluska | analyst |
John Newman | analyst |
Gil Blum | analyst |
Uy Ear | analyst |
Boobalan Pachaiyappan | analyst |
Good morning, everyone, and thank you for joining the Selecta Biosciences Q2 2023 Earnings Call. [Operator Instructions]
At this time, I'd like to turn the floor over to Blaine Davis Davis, Chief Financial Officer of Selecta. Please go ahead.
Good morning, everyone.